Results 71 to 80 of about 3,587 (183)

Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis

Frontiers in Pharmacology
BackgroundHepatorenal syndrome (HRS) bears a very poor prognosis with unmet need for safe and effective therapies. This systematic review and meta-analysis aimed to re-assess safety and efficacy of terlipressin versus placebo or noradrenaline for HRS ...
Yue-Meng Wan, Song-Quan Huang, Hua-Mei Wu, Yu-Hua Li, Hong-Jing Yin, Ying Xu   +5 more
doaj   +1 more source

Efficacy of low doses of terlipressin to prevent intra-operative blood loss in obstetrics

Вестник анестезиологии и реаниматологии, 2020
The use of modern blood-saving technologies is one of the effective methods of preventing intra-operative bleeding in obstetric practice, however, the effect of local use of terlipressin to reduce blood loss is not sufficiently investigated.The objective:
Yu. S. Аleksandrovich, A. V. Rostovtsev, E. S. Kononova, K. V. Pshenisnov, T. I. Аkimenko   +4 more
doaj   +1 more source

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of Pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe hepatic encephalopathy

, 2004
There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common.
Jalan, R., Hayes, P.C., Mookerjee, R.P., Shawcross, D.L., Williams, R., Lee, A., Davies, N.A.   +6 more
core  

A Case Study of Liver After Kidney Transplantation: Addressing Polycystic Diseases With Tailored Surgical and Postoperative Approaches

Clinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Polycystic liver disease is a hereditary disease, which is characterized by the presence of multiple cysts within the liver. In this case, we report a patient with multiple cysts in the kidneys and liver, who underwent kidney transplantation in 2019 and then liver transplantation 4 years later.
Chengjun Sun, Yang Du, Ming Han, Shaojun Shi, Linwei Wu   +4 more
wiley   +1 more source

Efektivitas dan Keamanan Terlipressin pada Acute Variceal Haemorhage: Sebuah Kajian Naratif

, 2020
Providing appropriate yet timely treatment to stop bleeding is the key pathway in the management of acute variceal haemorhage (AVH). Several agents can be used to manage bleeding, and one of the new agent recently approved in Indonesia in 2019 is ...
Setiawan, Eko, Halim, Steven Victoria
core   +1 more source

Pharmacotherapy for Cirrhosis in Japan

Portal Hypertension &Cirrhosis, Volume 4, Issue 2, Page 111-119, June 2025.
As cirrhosis progresses from the compensated to the decompensated stage, liver disease‐related events such as varices, ascites, encephalopathy, sarcopenia, jaundice, and bleeding tendency, as well as liver carcinogenesis, can occur at a high rate. With the advent of new pharmacotherapies for cirrhosis in the last decade, liver fibrosis has been shown ...
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
wiley   +1 more source

Terlipressin as rescue treatment of refractory shock in a neonate

, 2008
Patients with septic shock may develop refractory hypotension despite maximal inotropic support with impairment of clinical outcome. Terlipressin, a long-acting vasopressin analogue, is reported to be effective as rescue treatment of refractory septic ...
Poggi C., Serafini L., Filippi L., Fiorini P.   +3 more
core   +1 more source

A comparison of vasopressin, terlipressin, and lactated ringers for resuscitation of uncontrolled hemorrhagic shock in an animal model.

PLoS ONE, 2014
AimThe aim of this study is to compare the effect of lactated ringer (LR), vasopressin (Vaso) or terlipressin (Terli) on uncontrolled hemorrhagic shock (UHS) in rats.Methods48 rats were divided into four treatment groups for UHS study.
Chien-Chang Lee, Meng-Tse Gabriel Lee, Shy-Shin Chang, Si-Huei Lee, Yu-Chi Huang, Chia-Hung Yo, Shih-Hao Lee, Shyr-Chyr Chen   +7 more
doaj   +1 more source

Pregnancy Outcomes in Women With Liver Cirrhosis: A National Prospective Cohort Study Using the UK Obstetric Surveillance System

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 7, Page 935-943, June 2025.
ABSTRACT Objective Describe maternal/fetal outcomes of pregnant women with cirrhosis. Design Prospective, national cohort study utilising the UK Obstetric Surveillance System between 1st June 2017 and 30th November 2020. Setting UK. Population Pregnant women with cirrhosis.
Melanie Nana, Agata Majewska, Mussarat Rahim, Victoria Geenes, Caroline Ovadia, Marian Knight, Michael Heneghan, Catherine Williamson   +7 more
wiley   +1 more source